Research article
The metabolism of l-DOPA and l-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients

https://doi.org/10.1016/0022-510X(96)00049-4Get rights and content

Abstract

The monoamines and their metabolites were analyzed in the intraventricular fluid of parkinsonian patients treated with l-DOPA alone or together with l-threo-3,4-dihydroxyphenylserine (l-threo-DOPS), the precursor amino acids of dopamine and noradrenaline, respectively. In the intraventricular fluid of the patients administered with l-DOPA, the level of dopamine metabolites were higher than control, suggesting enhanced turnover of dopamine in the brain. However, l-DOPA administration increased free noradrenaline only slightly, and did not affect serotonin and its metabolite. On the other hand, by administration of l-DOPA combined with l-threo-DOPS, the levels of monoamines increased in general, whereas the monoamine metabolites by catechol-O-methyltransferase were reduced compared with those in the patients treated with l-DOPA alone. Only a minor part of l-threo-DOPS was metabolized into noradrenaline by aromatic l-amino acid decarboxylase, and it was metabolized mainly by two other enzymes, catechol-O-methyltransferase and DOPS-aldolase in the brain. An overview of the metabolism of neurotransmitters in the brain proved to be useful to evaluate the therapeutic effects of these precursor amino acids.

References (15)

There are more references available in the full text version of this article.

Cited by (0)

View full text